Novo Nordisk
NVO
#15
Rank
HK$4.388 T
Marketcap
HK$993.95
Share price
-5.46%
Change (1 day)
34.15%
Change (1 year)

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

Novo Nordisk (NVO) - Net assets

Net assets on the balance sheet as of June 2024 : HK$126.26 B

According to Novo Nordisk's latest financial reports the company has HK$126.26 B in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Novo Nordisk - Net assets on balance sheet (from 2001 to 2024)

Net assets by year

Year Net assets Change
2023-12-31$HK$123.25 B31.22%
2022-12-31$HK$93.93 B11.85%
2021-12-31$HK$83.98 B3.48%
2020-12-31$HK$81.16 B20.67%
2019-12-31$HK$67.25 B8.14%
2018-12-31$HK$62.19 B-0.88%
2017-12-31$HK$62.74 B26.24%
2016-12-31$HK$49.70 B-6.83%
2015-12-31$HK$53.34 B4.48%
2014-12-31$HK$51.06 B-16.45%
2013-12-31$HK$61.11 B9.44%
2012-12-31$HK$55.84 B10.21%
2011-12-31$HK$50.66 B-1.29%
2010-12-31$HK$51.33 B-3.85%
2009-12-31$HK$53.38 B10.96%
2008-12-31$HK$48.11 B-2.25%
2007-12-31$HK$49.21 B18.45%
2006-12-31$HK$41.54 B22.66%
2005-12-31$HK$33.87 B-0.4%
2004-12-31$HK$34.00 B2.39%
2003-12-31$HK$33.21 B25.25%
2002-12-31$HK$26.51 B14.03%
2001-12-31$HK$23.25 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
HK$685.77 B 443.14%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$106.28 B-15.82%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$133.05 B 5.38%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$609.97 B 383.11%๐Ÿ‡ซ๐Ÿ‡ท France